Kodiak Sciences Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Yes. Okay. Good afternoon, everyone. Welcome to the 4:40 p.m. session on day 1 of the 42nd Annual Goldman Sachs Global Health Care Conference. My name is Graig Suvannavejh. I cover both U.S. and European biopharma names here at the firm. It's my pleasure to be hosting Kodiak Sciences today in a fireside chat. And with that, let me welcome Victor Perlroth, who's CEO of the company; and John Borgeson, who is CFO of the company, who is just slightly to the side of your screen.
Questions & Answers
But with that said, Victor, it's good to see you. Thank you again for your participation. And maybe if I can just start everyone at a very high level for those who are perhaps newer to the Kodiak Sciences story or perhaps revisiting it after some time, can you please just tell us a little bit more about the company and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |